Laura Shawver
2021 - ARS Pharmaceuticals
In 2021, Laura Shawver earned a total compensation of $821.5K as Chief Executive Officer at ARS Pharmaceuticals, a 94% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $291,500 |
|---|---|
| Salary | $530,000 |
| Total | $821,500 |
Shawver received $530K in salary, accounting for 65% of the total pay in 2021.
Shawver also received $291.5K in non-equity incentive plan.
Rankings
In 2021, Laura Shawver's compensation ranked 9,408th out of 12,406 executives tracked by ExecPay. In other words, Shawver earned more than 24.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,408 out of 12,406 | 24th |
Division Manufacturing | 4,165 out of 5,492 | 24th |
Major group Chemicals And Allied Products | 1,842 out of 2,368 | 22nd |
Industry group Drugs | 1,634 out of 2,089 | 22nd |
Industry Pharmaceutical Preparations | 1,212 out of 1,536 | 21st |
Source: SEC filing on April 28, 2022.
Shawver's colleagues
We found two more compensation records of executives who worked with Laura Shawver at ARS Pharmaceuticals in 2021.
News
ARS Pharmaceuticals CEO Laura Shawver's 2022 pay jumps 608% to $5.8M
May 1, 2023
ARS Pharmaceuticals CEO Laura Shawver's 2021 pay falls 94% to $822K
April 28, 2022
ARS Pharmaceuticals CEO Laura Shawver receives $14M in 2020
April 22, 2021
Synthorx CEO Laura Shawver's 2018 pay jumps 3,349% to $5.2M
April 24, 2019